Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated
申请人:Merck & Co., Inc.
公开号:US05741796A1
公开(公告)日:1998-04-21
Compounds of the following general structure X-Y-Z-Aryl-A-B, for example, ##STR1## which inhibit osteoclast mediated bone resorption. Specifically, the compounds are useful for treating mammals suffering from a bone condition caused or mediated by increased bone resorption, who are in need of such therapy. The compounds may be administered in oral dosage forms such as tablets, capsules, e.g. sustained release capsules, powders, granules, and suspensions.